Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Epilepsy

  Free Subscription


Articles published in Brain Dev

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    December 2024
  1. KIKUCHI K, Kuki I, Nishiyama M, Ueda Y, et al
    Japanese guidelines for treatment of pediatric status epilepticus - 2023.
    Brain Dev. 2024;47:104306.
    PubMed     Abstract available


    November 2024
  2. WENG Y, Rao X, Ma B, Lin X, et al
    Efficacy, safety, and tolerability of adjunctive perampanel in the treatment of pediatric patients aged 4-18 years with epilepsy: A single-center, retrospective, observational real-world study.
    Brain Dev. 2024;47:104305.
    PubMed     Abstract available


  3. TSUCHIYA H, Shibata T, Sasaki T, Akiyama M, et al
    A retrospective study on post-operative recovery of daily living activity after total corpus callosotomy.
    Brain Dev. 2024;46:339-343.
    PubMed     Abstract available


    October 2024
  4. WU H, Huang C, Xiong S
    Gut microbiota as a potential therapeutic target for children with cerebral palsy and epilepsy.
    Brain Dev. 2024 Oct 18:S0387-7604(24)00127.
    PubMed     Abstract available


  5. SHIMOJIMA YAMAMOTO K, Shimomura R, Shoji H, Yamamoto T, et al
    Glass syndrome derived from chromosomal breakage downstream region of SATB2.
    Brain Dev. 2024;46:281-285.
    PubMed     Abstract available


    September 2024
  6. SHIDE-MORIGUCHI Y, Yamamoto N, Kuki I, Sakuma H, et al
    Myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis with super-refractory status epilepticus.
    Brain Dev. 2024 Sep 10:S0387-7604(24)00126.
    PubMed     Abstract available


    July 2024
  7. MITSUMATSU T, Ito Y, Maki Y, Yamamoto H, et al
    Epileptic foci and networks in children with epilepsy after acute encephalopathy with biphasic seizures and late reduced diffusion.
    Brain Dev. 2024 Jul 31:S0387-7604(24)00098.
    PubMed     Abstract available


    April 2024
  8. SILVA S, Rosas M, Guerra B, Munoz M, et al
    Adolescent-onset epilepsy and deterioration associated with CAD deficiency: A case report.
    Brain Dev. 2024 Apr 18:S0387-7604(24)00057.
    PubMed     Abstract available


    March 2024
  9. TAKEUCHI H, Higurashi N, Toga Y
    Prophylactic antiseizure medications for recurrent status epilepticus in nonsyndromic childhood epilepsy.
    Brain Dev. 2024 Mar 21:S0387-7604(24)00043.
    PubMed     Abstract available


  10. YUKSEL MF, Dogulu N, Yildirim M, Kose E, et al
    Metabolic etiologies in children with infantile epileptic spasm syndrome: Experience at a tertiary pediatric neurology center.
    Brain Dev. 2024 Mar 16:S0387-7604(24)00042.
    PubMed     Abstract available


    January 2024
  11. AKIYAMA T, Saigusa D, Inoue T, Tokorodani C, et al
    Exploration of urine metabolic biomarkers for new-onset, untreated pediatric epilepsy: A gas and liquid chromatography mass spectrometry-based metabolomics study.
    Brain Dev. 2024 Jan 2:S0387-7604(23)00209-7. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


    December 2023
  12. NISHIOKA M, Motobayashi M, Fukuyama T, Inaba Y, et al
    Risk factors for post-encephalopathic epilepsy in patients with acute encephalopathy with biphasic seizures and late reduced diffusion.
    Brain Dev. 2023 Dec 18:S0387-7604(23)00194.
    PubMed     Abstract available


  13. DE KNEGT VE, Borresen ML, Knudsen M, Thomsen KM, et al
    Current state of hemispherectomy and callosotomy for pediatric refractory epilepsy in Denmark.
    Brain Dev. 2023 Dec 2:S0387-7604(23)00179-1. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


    November 2023
  14. DILENA R, Striano P, Traverso M, Viri M, et al
    Corrigendum to "Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation" [Brain Dev. 38(1) (2016) 128-131].
    Brain Dev. 2023 Nov 24:S0387-7604(23)00176.
    PubMed    


  15. ANUAR MA, Lee JX, Musa H, Abd Hadi D, et al
    Severe and rare neurological manifestations following COVID-19 infection in children: A Malaysian tertiary centre experience.
    Brain Dev. 2023;45:547-553.
    PubMed     Abstract available


  16. AMORE G, Cali E, Spano M, Ceravolo G, et al
    ATP6V1B2-related disorders featuring Lennox-Gastaut-syndrome: A case-based overview.
    Brain Dev. 2023;45:588-596.
    PubMed     Abstract available


    October 2023
  17. UEDA Y, Furugen A, Kobayashi M, Sato Y, et al
    Use of lacosamide for focal epilepsy in a child with kidney failure undergoing peritoneal dialysis.
    Brain Dev. 2023 Oct 30:S0387-7604(23)00156.
    PubMed     Abstract available


  18. WATANABE Y, Yamanaka G, Morichi S, Hayashi K, et al
    Altered serum levels of platelet-derived growth factor receptor beta and cluster of differentiation 13 suggest a role for pericytes in West syndrome.
    Brain Dev. 2023;45:479-486.
    PubMed     Abstract available


    September 2023
  19. DAI L, Ding C, Tian X, Liu M, et al
    The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients.
    Brain Dev. 2023;45:422-431.
    PubMed     Abstract available


    August 2023
  20. SHIRAISHI H, Egawa K, Murakami K, Nakajima M, et al
    Transcutaneous auricular vagus nerve stimulation therapy in patients with cognitively preserved structural focal epilepsy: A case series report.
    Brain Dev. 2023 Aug 30:S0387-7604(23)00148.
    PubMed     Abstract available


  21. AKIYAMA M, Akiyama T, Saitsu H, Tokioka Y, et al
    A female patient with adolescent-onset progressive myoclonus epilepsy carrying a truncating MECP2 mutation.
    Brain Dev. 2023 Aug 5:S0387-7604(23)00116-X. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


  22. SANO K, Miya F, Kato M, Omata T, et al
    Neurochemistry evaluated by magnetic resonance spectroscopy in a patient with FBXO28-related developmental and epileptic encephalopathy.
    Brain Dev. 2023 Aug 3:S0387-7604(23)00113-4. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


    July 2023
  23. OKUBO Y, Shibuya M, Nakamura H, Kawashima A, et al
    Neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis: A case report with a novel missense variant of SCN1A.
    Brain Dev. 2023 Jul 11:S0387-7604(23)00110.
    PubMed     Abstract available


    June 2023
  24. KOBAYASHI Y, Honda R, Yamada K, Hojo M, et al
    Two-year efficacy of lacosamide as adjunctive therapy for generalized tonic-clonic seizures in patients with juvenile myoclonic epilepsy.
    Brain Dev. 2023 Jun 10:S0387-7604(23)00091.
    PubMed     Abstract available


  25. ROSSI J, Russo M, Gobbi G, Terracciano A, et al
    Developmental and epileptic encephalopathy in a young Italian woman with a de novo missense variant in the CLCN4 gene: A case report.
    Brain Dev. 2023 Jun 2:S0387-7604(23)00088-8. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


  26. HANAFUSA H, Yamaguchi H, Kondo H, Nagasaka M, et al
    Dravet syndrome and hemorrhagic shock and encephalopathy syndrome associated with an intronic deletion of SCN1A.
    Brain Dev. 2023;45:317-323.
    PubMed     Abstract available


    April 2023
  27. STUDER M, Schmitt S, Wingeier K, Lidzba K, et al
    Delayed episodic memory recall after one week is associated with executive functions and divided attention in pediatric epilepsy patients.
    Brain Dev. 2023 Apr 8:S0387-7604(23)00065-7. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


    March 2023
  28. MORI T, Sakamoto M, Tayama T, Goji A, et al
    A case of epilepsy with myoclonic atonic seizures caused by SLC6A1 gene mutation due to balanced chromosomal translocation.
    Brain Dev. 2023 Mar 23:S0387-7604(23)00044.
    PubMed     Abstract available


  29. SUN S, Li X, Liu X
    Efficacy, tolerability and safety of perampanel in children and adolescents with epilepsy: Systematic review and meta-analysis.
    Brain Dev. 2023 Mar 4:S0387-7604(23)00040-2. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


  30. SHIRAISHI H, Teramoto T, Yokoshiki S, Tohyama J, et al
    Efficacy of sirolimus for epileptic seizures in childhood associated with focal cortical dysplasia type II.
    Brain Dev. 2023 Mar 2:S0387-7604(23)00028-1. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


  31. POLITANO D, Gana S, Pezzotti E, Berardinelli A, et al
    A novel variant in NEUROD2 in a patient with Rett-like phenotype points to Glu130 codon as a mutational hotspot.
    Brain Dev. 2023;45:179-184.
    PubMed     Abstract available


    February 2023
  32. OZKAN KART P, Citli S, Yildiz N, Cansu A, et al
    A novel INPP4A mutation with pontocerebellar hypoplasia, myoclonic epilepsy, microcephaly, and severe developmental delay.
    Brain Dev. 2023 Feb 7:S0387-7604(23)00019-0. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


  33. YAMAMOTO Y, Ohta A, Usui N, Imai K, et al
    Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy.
    Brain Dev. 2023 Feb 7:S0387-7604(23)00020-7. doi: 10.1016/j.braindev.2023.
    PubMed     Abstract available


  34. WATANABE Y, Odaka M, Motoi H, Oyama Y, et al
    Neurological prognostic factors for human herpes virus 6/7-associated acute encephalopathy in children: A single-center study.
    Brain Dev. 2023;45:102-109.
    PubMed     Abstract available


    January 2023
  35. BONARDI CM, Furlanis GM, Toldo I, Guarrera B, et al
    Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?
    Brain Dev. 2023 Jan 30:S0387-7604(23)00004.
    PubMed     Abstract available


  36. KAWANO O, Saito T, Sumitomo N, Takeshita E, et al
    Skeletal anomaly and opisthotonus in early-onset epileptic encephalopathy with KCNQ2 abnormality.
    Brain Dev. 2023 Jan 9:S0387-7604(22)00221-2. doi: 10.1016/j.braindev.2022.
    PubMed     Abstract available


    December 2022
  37. LI J, Zhou Y, Su T, Xu S, et al
    Perampanel therapy for intractable GRIN2D-related developmental and epileptic encephalopathy: A case report and literature review.
    Brain Dev. 2022 Dec 23:S0387-7604(22)00208.
    PubMed     Abstract available


    November 2022
  38. OHTA K, Okanishi T, Kanai S, Nakamura Y, et al
    Stimulus-induced focal motor seizure in a pediatric patient with carbamazepine overdose.
    Brain Dev. 2022;44:765-768.
    PubMed     Abstract available


    October 2022
  39. UEMATSU K, Matsumoto H, Zaha K, Mizuguchi M, et al
    Prediction and assessment of acute encephalopathy syndromes immediately after febrile status epilepticus.
    Brain Dev. 2022 Oct 31. pii: S0387-7604(22)00172.
    PubMed     Abstract available


  40. HU Q, Luo Y, Li T, Ma J, et al
    Early-onset spontaneously relieved spasms of infancy in sleep: Electroclinical characteristics and differential diagnoses.
    Brain Dev. 2022;44:612-617.
    PubMed     Abstract available


    September 2022
  41. SAGER SG, Turkyilmaz A, Gunbey HP, Karatoprak EY, et al
    A novel de novo TET3 loss-of-function variant in a Turkish boy presenting with neurodevelopmental delay and electrical status epilepticus during slow-wave sleep.
    Brain Dev. 2022 Sep 30. pii: S0387-7604(22)00163.
    PubMed     Abstract available


  42. SUNAGA Y, Takayama Y, Yokosako S, Mizuno T, et al
    Drug-resistant temporal lobe epilepsy due to middle fossa meningoencephalocele in a child: A surgical case report.
    Brain Dev. 2022 Sep 14. pii: S0387-7604(22)00158.
    PubMed     Abstract available


  43. MORIYAMA K, Mizuno T, Suzuki T, Inaji M, et al
    ATP1A3-related early childhood onset developmental and epileptic encephalopathy responding to corpus callosotomy: A case report.
    Brain Dev. 2022 Sep 13. pii: S0387-7604(22)00159.
    PubMed     Abstract available


  44. HASHIMOTO K, Baba S, Nakagawa E, Sumitomo N, et al
    Long-term changes in electroencephalogram findings in a girl with a nonsense SMC1A variant: A case report.
    Brain Dev. 2022;44:551-557.
    PubMed     Abstract available


  45. TAKEDA Y, Sakakibara T, Ogiwara K, Nogami K, et al
    Blood coagulation dynamics during adrenocorticotropic hormone therapy in pediatric patients with infantile spasms.
    Brain Dev. 2022;44:546-550.
    PubMed     Abstract available


    August 2022
  46. SAITO M, Murai T, Motobayashi M, Ono S, et al
    Refractory status epilepticus with fever due to mumps vaccine-induced encephalitis caused secondary encephalopathy mimicking acute encephalopathy with biphasic seizures and late reduced diffusion.
    Brain Dev. 2022 Aug 24. pii: S0387-7604(22)00153.
    PubMed     Abstract available


  47. GIACOMINI T, Scala M, Nobile G, Severino M, et al
    De novo POLR2A p.(Ile457Thr) variant associated with early-onset encephalopathy and cerebellar atrophy: expanding the phenotypic spectrum.
    Brain Dev. 2022;44:480-485.
    PubMed     Abstract available


  48. D'ONOFRIO G, Riva A, Di Rosa G, Cali' E, et al
    Paroxysmal limb dystonias associated with GABBR2 pathogenic variant: A case-based literature review.
    Brain Dev. 2022;44:469-473.
    PubMed     Abstract available


  49. KOMATSU K, Fukumura S, Minagawa K, Nakashima M, et al
    A new case of concurrent existence of PRRT2-associated paroxysmal movement disorders with c.649dup variant and 16p11.2 microdeletion syndrome.
    Brain Dev. 2022;44:474-479.
    PubMed     Abstract available


    July 2022
  50. SAKATA Y, Nakamura T, Matsuo M
    Reply: Amnestic aphasia in MELAS can be epileptogenic.
    Brain Dev. 2022 Jul 7. pii: S0387-7604(22)00109.
    PubMed    


    June 2022
  51. FINSTERER J
    Amnestic aphasia in MELAS can be epileptogenic.
    Brain Dev. 2022 Jun 14. pii: S0387-7604(22)00101.
    PubMed    


  52. FUKUOKA M, Kuki I, Hattori Y, Tsuji H, et al
    A case of focal cortical dysplasia type IIa with pathologically suspected bilateral Rasmussen syndrome.
    Brain Dev. 2022;44:401-404.
    PubMed     Abstract available


  53. KAWAKAMI S, Kubota M, Terashima H, Nagata C, et al
    Differentiating early clinical features of Panayiotopoulos syndrome from acute encephalopathy.
    Brain Dev. 2022;44:386-390.
    PubMed     Abstract available


    April 2022
  54. IIMURA Y, Nakazawa M, Suzuki H, Mitsuhashi T, et al
    Surgery for intractable epilepsy after severe encephalopathy with reversible splenial lesion and new onset hippocampal lesion associated with parechovirus.
    Brain Dev. 2022 Apr 4. pii: S0387-7604(22)00049.
    PubMed     Abstract available


    March 2022
  55. OHNO A, Okumura A, Fukasawa T, Nakata T, et al
    Acute encephalopathy with biphasic seizures and late reduced diffusion: Predictive EEG findings.
    Brain Dev. 2022;44:221-228.
    PubMed     Abstract available


    February 2022
  56. OKANISHI T, Fujii Y, Sakuma S, Shiraishi H, et al
    Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes.
    Brain Dev. 2022 Feb 28. pii: S0387-7604(22)00024.
    PubMed     Abstract available


  57. SAKATA Y, Sano K, Aoki S, Saitsu H, et al
    Neurochemistry evaluated by MR spectroscopy in a patient with SPTAN1-related developmental and epileptic encephalopathy.
    Brain Dev. 2022 Feb 23. pii: S0387-7604(22)00020.
    PubMed     Abstract available


  58. KIKUCHI K, Hamano SI, Matsuura R, Nonoyama H, et al
    The effectiveness of intravenous benzodiazepine for status epilepticus in Dravet syndrome.
    Brain Dev. 2022 Feb 1. pii: S0387-7604(22)00006.
    PubMed     Abstract available


  59. JHA R, Kurup A, Kovilapu UB, Ranjan R, et al
    Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.
    Brain Dev. 2022;44:166-172.
    PubMed     Abstract available


  60. GRABER D, Imagawa E, Miyake N, Matsumoto N, et al
    Polymicrogyria in a child with KCNMA1-related channelopathy.
    Brain Dev. 2022;44:173-177.
    PubMed     Abstract available


  61. MATSUURA R, Hamano SI, Daida A, Horiguchi A, et al
    Serum matrix metallopeptidase-9 and tissue inhibitor of metalloproteinase-1 levels may predict response to adrenocorticotropic hormone therapy in patients with infantile spasms.
    Brain Dev. 2022;44:114-121.
    PubMed     Abstract available


    January 2022
  62. TAHARA M, Higurashi N, Narita A, Ida H, et al
    Long-term efficacy of low-dose perampanel for progressive myoclonus epilepsy in a patient with Gaucher disease type 3.
    Brain Dev. 2022 Jan 3. pii: S0387-7604(21)00230.
    PubMed     Abstract available


  63. HADI DA, Mohamed AR, Rethanavelu K, Khoo TB, et al
    Clonic seizures, continuous spikes-and-waves during slow sleep, choreoathetosis and response to sulthiame in a child with FRRS1L encephalopathy.
    Brain Dev. 2022;44:44-49.
    PubMed     Abstract available


    December 2021
  64. CHEN J, Liu P, Hu W, Shi K, et al
    Absence seizures during sleep in childhood absence epilepsy: A sign of drug resistance?
    Brain Dev. 2021 Dec 9. pii: S0387-7604(21)00213.
    PubMed     Abstract available


    November 2021
  65. CHAN DL, Rudinger-Thirion J, Frugier M, Riley LG, et al
    A case of QARS1 associated epileptic encephalopathy and review of epilepsy in aminoacyl-tRNA synthetase disorders.
    Brain Dev. 2021 Nov 10. pii: S0387-7604(21)00203.
    PubMed     Abstract available


  66. NAKAMURA Y, Okanishi T, Yamada H, Okazaki T, et al
    Progressive cerebral atrophies in three children with COL4A1 mutations.
    Brain Dev. 2021;43:1033-1038.
    PubMed     Abstract available


  67. BOUHADOUN S, Poulin C, Berrahmoune S, Myers KA, et al
    A retrospective analysis of memantine use in a pediatric neurology clinic.
    Brain Dev. 2021;43:997-1003.
    PubMed     Abstract available


    October 2021
  68. YAMAGUCHI H, Nishiyama M, Tomioka K, Hongo H, et al
    Growth and differentiation factor-15 as a potential prognostic biomarker for status-epilepticus-associated-with-fever: A pilot study.
    Brain Dev. 2021 Oct 27. pii: S0387-7604(21)00187.
    PubMed     Abstract available


  69. ONO-TAKIGUCHI Y, Muramatsu K, Koshu K, Yamagata T, et al
    Forced normalization of Lennox-Gastaut syndrome using lacosamide: A case report.
    Brain Dev. 2021;43:963-966.
    PubMed     Abstract available


    September 2021
  70. KIRIKAE H, Uematsu M, Numata-Uematsu Y, Saijo N, et al
    Two types of early epileptic encephalopathy in a Pitt-Hopkins syndrome patient with a novel TCF4 mutation.
    Brain Dev. 2021 Sep 24. pii: S0387-7604(21)00174.
    PubMed     Abstract available


  71. TAKAMI Y, Nakagawa T
    Risk of seizure recurrence after a first unprovoked seizure in childhood.
    Brain Dev. 2021;43:843-850.
    PubMed     Abstract available


    August 2021
  72. KASHIKI T, Kido J, Momosaki K, Kusunoki S, et al
    Mitochondrial DNA depletion syndrome with a mutation in SLC25A4 developing epileptic encephalopathy: A case report.
    Brain Dev. 2021 Aug 25. pii: S0387-7604(21)00155.
    PubMed     Abstract available


  73. ICHINOSE F, Nakamura T, Kira R, Furuno K, et al
    Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus.
    Brain Dev. 2021 Aug 3. pii: S0387-7604(21)00132.
    PubMed     Abstract available


    July 2021
  74. TAIRA R, Yamamura K, Maeda T, Sakata A, et al
    Paroxysmal sympathetic hyperactivity and the later development of epilepsy in a chemotherapy-associated brain damage.
    Brain Dev. 2021 Jul 20. pii: S0387-7604(21)00129.
    PubMed     Abstract available


  75. COHEN H, Kramer U, Hausman-Kedem M, Uliel-Siboni S, et al
    Dosage of cannabidiol-enriched cannabis in children and adults with epilepsy.
    Brain Dev. 2021 Jul 2. pii: S0387-7604(21)00124.
    PubMed    


    June 2021
  76. CHEN W, Qin J, Shen Y, Liang J, et al
    Next generation sequencing in children with unexplained epilepsy: A retrospective cohort study.
    Brain Dev. 2021 Jun 10. pii: S0387-7604(21)00103.
    PubMed     Abstract available


  77. MATSUMOTO A, Kojima K, Miya F, Miyauchi A, et al
    Two cases of DYNC1H1 mutations with intractable epilepsy.
    Brain Dev. 2021 Jun 3. pii: S0387-7604(21)00094.
    PubMed     Abstract available


  78. AZUMAGAWA K, Nakashima I, Kaneko K, Torisu H, et al
    A nation-wide survey of Japanese pediatric MOG antibody-associated diseases.
    Brain Dev. 2021;43:705-713.
    PubMed     Abstract available


    May 2021
  79. HIRATA K, Sugawara Y, Hoshino A, Takeda S, et al
    Nonconvulsive status epilepticus following rotavirus gastroenteritis in two pediatric patients.
    Brain Dev. 2021 May 29. pii: S0387-7604(21)00098.
    PubMed     Abstract available


  80. OKA M, Kobayashi K, Shibata T, Tsuchiya H, et al
    A study on the relationship between non-epileptic fast (40 - 200 Hz) oscillations in scalp EEG and development in children.
    Brain Dev. 2021 May 26. pii: S0387-7604(21)00091.
    PubMed     Abstract available


  81. TIAN Q, Li H, Shu L, Wang H, et al
    Effective treatments for FGF12-related early-onset epileptic encephalopathies patients.
    Brain Dev. 2021 May 18. pii: S0387-7604(21)00088.
    PubMed     Abstract available


  82. ZHANG Y, Ichinose F, Maeda T, Nakamura T, et al
    A pediatric case of transient periictal MRI abnormalities after repeated seizures.
    Brain Dev. 2021 May 3. pii: S0387-7604(21)00066.
    PubMed     Abstract available


  83. SUZUKI Y, Ito S, Otani Y, Nishikawa A, et al
    Unexpected elevation in valproic acid concentration and agranulocytosis in a patient with short-chain acyl-CoA dehydrogenase deficiency.
    Brain Dev. 2021;43:657-660.
    PubMed     Abstract available


  84. IZUMI T, Aihara Y, Kikuchi A, Kure S, et al
    Electroencephalographic findings and genetic characterization of two brothers with IQSEC2 pathogenic variant.
    Brain Dev. 2021;43:652-656.
    PubMed     Abstract available


  85. YAMAMOTO N, Kuki I, Nagase S, Inoue T, et al
    A case of infantile Tay-Sachs disease with late onset spasms.
    Brain Dev. 2021;43:661-665.
    PubMed     Abstract available


    April 2021
  86. KASRADZE S, Lomidze G, Cross JH, Kvernadze D, et al
    A six-year longitudinal study of neurocognitive problems in children with epilepsy.
    Brain Dev. 2021 Apr 20. pii: S0387-7604(21)00064.
    PubMed     Abstract available


  87. OGUNI H, Ito S, Nishikawa A, Otani Y, et al
    Morphometric analysis of spike-wave complexes (SWCs) causing myoclonic seizures in children with idiopathic myoclonic epilepsies - A positive SWC component correlates with myoclonic intensity.
    Brain Dev. 2021 Apr 16. pii: S0387-7604(21)00058.
    PubMed     Abstract available


  88. NEGISHI Y, Aoki Y, Itomi K, Yasuda K, et al
    SCN8A-related developmental and epileptic encephalopathy with ictal asystole requiring cardiac pacemaker implantation.
    Brain Dev. 2021 Apr 4. pii: S0387-7604(21)00061.
    PubMed     Abstract available


    March 2021
  89. BATTAGLIA D, Chieffo D, Lucibello S, Marini C, et al
    Multicenter prospective longitudinal study in 34 patients with Dravet syndrome: Neuropsychological development in the first six years of life.
    Brain Dev. 2021;43:419-430.
    PubMed     Abstract available


  90. KANATANI M, Adachi T, Sakata R, Nishimura Y, et al
    Dravet syndrome with parkinsonian symptoms and intact dopaminergic neurons: A case report.
    Brain Dev. 2021;43:486-489.
    PubMed     Abstract available


    February 2021
  91. BAMBORSCHKE D, Kreutzer M, Koy A, Koerber F, et al
    PNPT1 mutations may cause Aicardi-Goutieres-Syndrome.
    Brain Dev. 2021;43:320-324.
    PubMed     Abstract available


  92. GEIER DA, Geier MR
    A longitudinal cohort study of childhood MMR vaccination and seizure disorder among American children.
    Brain Dev. 2021;43:251-267.
    PubMed     Abstract available


  93. YOO S, Kim YA, Yoon JY, Seo GH, et al
    The first Korean cases of combined oxidative phosphorylation deficiency 35 with two novel TRIT1 mutations in two siblings confirmed by clinical and molecular investigation.
    Brain Dev. 2021;43:325-330.
    PubMed     Abstract available


  94. KIM HJ, Yang D, Kim SH, Won D, et al
    Clinical characteristics of KCNQ2 encephalopathy.
    Brain Dev. 2021;43:244-250.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.